Perry Fukui

Perry Fukui has a diverse work experience in various companies and industries. Perry started their career in 1985 as the Manager of Operations at PharmChem Laboratories, where they successfully managed the relocation of operations to a new facility and started operations for a new laboratory in Texas. In 1997, they joined Target Therapeutics, a division of Boston Scientific, as the Manager of R&D. During their tenure, they reorganized the R&D project management support structure and led the development of the Excelsior Petite microcatheter.

In 2002, Perry Fukui became the Director of Operations at FlowCardia, a medical device start-up. Perry managed all facets of operations, including supply chain management and implementing ERP/MRP systems. Perry remained with the company until 2013.

From 2013 to 2017, Perry Fukui worked as a Consultant in Quality and Operations at CardioProlific, Inc. Perry developed and implemented a quality system for medical device manufacturing and created various documentation, such as SOPs and material specifications.

In 2014, they joined BioTrace Medical Inc. as the Director of Quality and Operations, where they remained until 2016.

Most recently, Perry Fukui served as the VP of Quality and Operations at Cerus Endovascular Inc, starting in 2016. The details of their role are not provided, but it can be inferred that they were responsible for overseeing quality and operations within the company.

Perry Fukui attended San Jose State University from 1978 to 1983, where they earned a Bachelor of Arts (B.A.) degree in Molecular Biology.